On Monday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.2 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.1. The stock opened at $27.52 ...

Gland Pharma Q2 Results Live : Gland Pharma declared their Q2 results on 04 Nov, 2024, reporting a topline increase of 2.36% ...

SWING STATE SNAPSHOTS — The final day of the election has arrived, as millions of Americans line up at the polls to cast ...

A South Florida company aims to grow its presence in Europe as more countries reconsider their policies on cannabis.

The US FDA has approved Vyloy in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of advanced gastric or gastroesophageal junction cancer.

Mexican-American Pablo Legorreta founded Royalty Pharma, which provides funding to pharmaceutical developers in exchange for ...

Quincy Jones worked with Michael Jackson on three of his albums. The pair had an incredibly successful working relationship, and Jones described Jackson as his brother following the latter’s death.

Dr John Cormack, who has been looking into the prevalence of deepfake doctors online, outlines the dangers of misinformation ...

Both Harris and Trump made closing arguments to voters across swing states over the weekend and Monday. Each promised vastly ...

Mankind Pharma on Tuesday reported a 29 per cent rise in its consolidated net profit to Rs 658.88 crore for the second quarter ended September 2024, helped by recovery in volume. The company posted a ...

To help foot the bill to launch its approved graft-versus-host disease drug Niktimvo and the expected launch of its leukemia treatment revumenib, Syndax has struck a $350 million licensing deal with ...

Henlius and Organon’s pertuzumab biosimilar met phase 3 goals; Meitheal expanded its US biosimilars; Celltrion’s subcutaneous infliximab (Zymfentra) showed monotherapy could be as effective as ...